| 000 | 01471 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515013039.0 | ||
| 264 | 0 | _c20060629 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/01.ftd.0000179839.71138.6d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDerijks, Luc J J | |
| 245 | 0 | 0 |
_aPharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cFeb 2006 |
||
| 300 |
_a45-50 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThioguanine _xadverse effects |
| 700 | 1 | _aGilissen, Lennard P L | |
| 700 | 1 | _aEngels, Leopold G J B | |
| 700 | 1 | _aBos, Laurens P | |
| 700 | 1 | _aBus, Paul J | |
| 700 | 1 | _aLohman, Joseph J H M | |
| 700 | 1 | _avan Deventer, Sander J H | |
| 700 | 1 | _aHommes, Daniel W | |
| 700 | 1 | _aHooymans, Piet M | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 28 _gno. 1 _gp. 45-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ftd.0000179839.71138.6d _zAvailable from publisher's website |
| 999 |
_c16034826 _d16034826 |
||